BMY vs. T
Compare and contrast key facts about Bristol-Myers Squibb Company (BMY) and AT&T Inc. (T).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BMY or T.
Key characteristics
BMY | T | |
---|---|---|
YTD Return | -11.82% | 4.15% |
1Y Return | -32.29% | 6.19% |
3Y Return (Ann) | -7.72% | -3.90% |
5Y Return (Ann) | 1.46% | 1.52% |
10Y Return (Ann) | 1.82% | 2.89% |
Sharpe Ratio | -1.53 | 0.15 |
Daily Std Dev | 21.28% | 24.44% |
Max Drawdown | -70.62% | -63.88% |
Current Drawdown | -42.25% | -19.81% |
Fundamentals
BMY | T | |
---|---|---|
Market Cap | $90.90B | $120.10B |
EPS | -$3.10 | $1.86 |
PE Ratio | 12.68 | 9.01 |
PEG Ratio | 2.24 | 1.27 |
Revenue (TTM) | $45.53B | $122.32B |
Gross Profit (TTM) | $36.38B | $69.89B |
EBITDA (TTM) | $18.20B | $42.35B |
Correlation
The correlation between BMY and T is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BMY vs. T - Performance Comparison
In the year-to-date period, BMY achieves a -11.82% return, which is significantly lower than T's 4.15% return. Over the past 10 years, BMY has underperformed T with an annualized return of 1.82%, while T has yielded a comparatively higher 2.89% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BMY vs. T - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and AT&T Inc. (T). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BMY vs. T - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 5.29%, less than T's 6.56% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol-Myers Squibb Company | 5.29% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
AT&T Inc. | 6.56% | 6.62% | 7.35% | 11.19% | 9.58% | 6.91% | 9.28% | 6.67% | 5.98% | 7.23% | 7.25% | 6.78% |
Drawdowns
BMY vs. T - Drawdown Comparison
The maximum BMY drawdown since its inception was -70.62%, which is greater than T's maximum drawdown of -63.88%. Use the drawdown chart below to compare losses from any high point for BMY and T. For additional features, visit the drawdowns tool.
Volatility
BMY vs. T - Volatility Comparison
Bristol-Myers Squibb Company (BMY) has a higher volatility of 9.79% compared to AT&T Inc. (T) at 4.95%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than T based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BMY vs. T - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and AT&T Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities